Minsi Li

514 total citations
11 papers, 433 citations indexed

About

Minsi Li is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Minsi Li has authored 11 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biomaterials, 5 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Minsi Li's work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Minsi Li is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Minsi Li collaborates with scholars based in China, United States and Israel. Minsi Li's co-authors include Chuanchuan He, Pengxuan Zhao, Guangya Xiang, Yao Lu, Xiaojuan Zhang, Robert J. Lee, Tan Yang, Ruicong Yan, Ting Fan and Xiang Ma and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Acta Biomaterialia.

In The Last Decade

Minsi Li

11 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minsi Li China 9 188 188 160 98 72 11 433
Kan He China 12 141 0.8× 190 1.0× 319 2.0× 112 1.1× 84 1.2× 20 662
Pasupathi Sundaramoorthy United States 13 139 0.7× 105 0.6× 209 1.3× 42 0.4× 57 0.8× 17 445
Lingran Du China 11 109 0.6× 141 0.8× 188 1.2× 63 0.6× 59 0.8× 22 457
Mohamed J. Saadh Jordan 4 204 1.1× 224 1.2× 208 1.3× 51 0.5× 103 1.4× 17 574
Jibin Guan China 12 156 0.8× 123 0.7× 230 1.4× 80 0.8× 37 0.5× 29 501
Mabrouk A. Abo‐Zaid Saudi Arabia 3 204 1.1× 225 1.2× 201 1.3× 49 0.5× 104 1.4× 6 562
Kave Moloudi South Africa 12 118 0.6× 169 0.9× 101 0.6× 38 0.4× 58 0.8× 21 384
Chunjuan Zheng China 9 81 0.4× 235 1.3× 133 0.8× 66 0.7× 52 0.7× 10 452
Mingzhen Lin China 10 70 0.4× 107 0.6× 171 1.1× 74 0.8× 40 0.6× 17 412
Funmilola A. Fisusi Nigeria 6 154 0.8× 129 0.7× 196 1.2× 65 0.7× 28 0.4× 10 499

Countries citing papers authored by Minsi Li

Since Specialization
Citations

This map shows the geographic impact of Minsi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minsi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minsi Li more than expected).

Fields of papers citing papers by Minsi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minsi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minsi Li. The network helps show where Minsi Li may publish in the future.

Co-authorship network of co-authors of Minsi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Minsi Li. A scholar is included among the top collaborators of Minsi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minsi Li. Minsi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Li, Minsi, Guo Xiang, & Roman Goltsberg. (2023). Efficient Sub-Modeling for Adhesive Wear in Elastic–Plastic Spherical Contacts. Lubricants. 11(5). 228–228. 4 indexed citations
3.
Zhang, Xiaojuan, Chuanchuan He, Xiaoguang Liu, et al.. (2020). One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy. Theranostics. 10(7). 2918–2929. 36 indexed citations
4.
Chen, Yan, Chen Chen, Xiaojuan Zhang, et al.. (2019). Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects. Acta Pharmaceutica Sinica B. 10(6). 1106–1121. 81 indexed citations
5.
Zhao, Pengxuan, Minsi Li, Yan Chen, et al.. (2019). Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects. International Journal of Pharmaceutics. 570. 118638–118638. 19 indexed citations
6.
Li, Minsi, Pengxuan Zhao, Ting Fan, et al.. (2019). Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma. International Journal of Pharmaceutics. 572. 118769–118769. 12 indexed citations
7.
Zhang, Xiaojuan, Chuanchuan He, Ruicong Yan, et al.. (2019). HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy. Chemical Engineering Journal. 380. 122540–122540. 41 indexed citations
8.
He, Chuanchuan, Xiaojuan Zhang, Ruicong Yan, et al.. (2019). Enhancement of cisplatin efficacy by lipid–CaO2 nanocarrier-mediated comprehensive modulation of the tumor microenvironment. Biomaterials Science. 7(10). 4260–4272. 55 indexed citations
9.
Zhao, Pengxuan, Minsi Li, Yao Wang, et al.. (2018). Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles. Acta Biomaterialia. 72. 248–255. 74 indexed citations
10.
Chen, Yan, Yao Cheng, Pengxuan Zhao, et al.. (2018). Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance. International Journal of Pharmaceutics. 542(1-2). 266–279. 53 indexed citations
11.
Zhao, Pengxuan, Yao Cheng, Jia You, et al.. (2017). MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2507–2516. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kan He Breakdown of academic impact, for papers by Pasupathi Sundaramoorthy Breakdown of academic impact, for papers by Lingran Du Breakdown of academic impact, for papers by Mohamed J. Saadh Breakdown of academic impact, for papers by Jibin Guan Breakdown of academic impact, for papers by Mabrouk A. Abo‐Zaid Breakdown of academic impact, for papers by Kave Moloudi Breakdown of academic impact, for papers by Chunjuan Zheng Breakdown of academic impact, for papers by Mingzhen Lin Breakdown of academic impact, for papers by Funmilola A. Fisusi
Rankless by CCL
2026